Myopathy‐linked mutations in TPM2 and their impact on troponin‐mediated regulation of actomyosin contractility
The FEBS Journal · 2025
DOI: 10.1111/febs.70180 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Recep Küçükdogru und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Cell Biology, Faculty of Biological Sciences, Kazimierz Wielki University, Bydgoszcz, Poland. Hauptthemen laut MEDLINE: Tropomyosin, Actomyosin, Muscle Contraction, Troponin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Polish Minister of Education and Science under the Program "Regional Initiative of Excellence" in 2019-2023.
Abstract (Originalsprache)
In striated muscle, the regulatory complex of tropomyosin (Tpm) and troponin (Tn) governs the Ca 2+ ‐dependent interactions between myosin heads and actin, controlling muscle contraction. The N‐terminal and central regions of Tpm are crucial for Tn binding, yet their roles in regulating contraction in concert with Tn remain poorly understood. To explore this, we selected four pathogenic missense mutations in the TPM2 gene encoding the skeletal Tpm2.2 isoform (β‐tropomyosin): D20H and E181K, associated with hypercontractility, and E41K and N202K, linked to hypocontractility. Using in vitro functional assays, we characterized these Tpm2.2 variants to unravel details of the molecular mechanisms underlying disease phenotypes. At low, non‐activating Ca 2+ , all Tpm2.2 variants inhibited the Tn‐regulated steady‐state actomyosin ATPase reaction without affecting Tn binding to actin. At activating Ca 2+ , hypocontractile mutants suppressed actomyosin ATPase activity and motor function more than wild‐type, suggesting interference with normal Tn regulation. Conversely, hypercontractile mutants enhanced myosin‐driven actin translocation. Arrhenius plots revealed a limited ability of E181K mutant to activate Tn‐regulated actomyosin ATPase at temperatures below 30 °C, which was fully recovered, and even enhanced, at physiological temperatures. In the absence of actin, the N‐terminal mutations enhanced high‐affinity Tpm2.2‐Tn interactions, whereas central mutations had no effect. Additionally, although hypercontractile mutations increased Ca 2+ ‐sensitivity of the cross‐bridge cycle, hypocontractile mutants decreased it. These findings demonstrate that mutations in the N‐terminal and central segments of Tpm2.2 disrupt Tn‐dependent regulation of actomyosin contractility through distinct mechanisms, providing new insights into the pathophysiology of Tpm‐related myopathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Cell Biology, Faculty of Biological Sciences, Kazimierz Wielki University, Bydgoszcz, Poland.
- Cellular Biophysics, Institute for Biophysical Chemistry, Hannover Medical School, Germany.
ORCID-Profile: Joanna Moraczewska
Förderung
- Polish Minister of Education and Science under the Program "Regional Initiative of Excellence" in 2019-2023
Zitieren
APA
Küçükdogru, R., Robaszkiewicz, K., Siatkowska, M., Franz, P., Tsiavaliaris, G., & Moraczewska, J. (2025). Myopathy‐linked mutations in TPM2 and their impact on troponin‐mediated regulation of actomyosin contractility. The FEBS Journal. https://doi.org/10.1111/febs.70180
Vancouver
Küçükdogru R, Robaszkiewicz K, Siatkowska M, Franz P, Tsiavaliaris G, Moraczewska J. Myopathy‐linked mutations in TPM2 and their impact on troponin‐mediated regulation of actomyosin contractility. The FEBS Journal. 2025. doi:10.1111/febs.70180
BibTeX
@article{Kkdogru2025,
author = {Küçükdogru, Recep and Robaszkiewicz, Katarzyna and Siatkowska, Małgorzata and Franz, Peter and Tsiavaliaris, Georgios and Moraczewska, Joanna},
title = {Myopathy‐linked mutations in TPM2 and their impact on troponin‐mediated regulation of actomyosin contractility},
journal = {The FEBS Journal},
year = {2025},
doi = {10.1111/febs.70180}
}
EUVIMED